packageMolnupiravir

molnupiravir

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Molnupiravir is an antiviral drug that was developed for the treatment of COVID-19 infection. Its marketing authorisation application in the European Union was withdrawn, and it remains investigational rather than an approved medicine.

Summary written by glm-5.3-flash from Wikidata Q96376832 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:molnupiravir
ATC codes:J05AB18
DrugBank:DB15661
PubChem CID:145996610
Wikidata:Q96376832
formula:C13H19N3O7
molar mass:329.309 g/mol (PubChem CID 145996610)
logP:-0.8 (Drugs.Common 25.09, not verified)

Metabolites

NHCDN4HydroxycytidineNHC (β-D-N4-hydroxycytidine) (NHC)259.218 g/mol (pubchem)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown

Contents

NameDescription
NHCDN4Hydroxycytidinemetabolite: NHC (β-D-N4-hydroxycytidine)